We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Diagnostics

Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

A new liquid biopsy detects minimal residual disease and predicts early NSCLC recurrence months before imaging. More...
21 Oct 2026
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting. More...
21 Oct 2026
Image Credit: iStock

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

A new in-house genetic testing model cuts diagnosis of pediatric immune disorders from 12 months to as little as two weeks. More...
20 Oct 2026
Image Credit: iStock

Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

A new blood test analyzes rare cells and vesicles to complement mammography and detect Stage I breast cancer. More...
20 Oct 2026
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

An RNA-based test integrating tumor-immune signals predicts NSCLC immunotherapy response. More...
19 Oct 2026
Image: Shield is a blood-based CRC screening test that uses methylation partitioning cell-free DNA (mp-cfDNA) technology to detect colorectal cancer-associated alterations (Photo courtesy of Guardant Health, Inc.)

Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests

New data show a blood-based colorectal cancer screening test boosts adherence and colonoscopy uptake. More...
19 Oct 2026
Image: The newly released  RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX Platform (Photo courtesy of Nabsys)

Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

A newly launched analysis pipeline now uses electronic genome mapping data to investigate disease-associated repeat expansions More...
18 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Aspiration System
VACUSAFE


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.